Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

Journal of neuro-oncology - 1 Nov 2013

Odia Yazmin, Orr Brent A, Bell W Robert, Eberhart Charles G, Rodriguez Fausto J

Abstract excerpt

Gliomas are among the most frequent adult primary brain tumors. Mutations in IDH1, a metabolic enzyme, strongly correlate with secondary glioblastomas and increased survival. cMYC is an oncogene also implicated in aberrant metabolism, but its prognostic impact remains unclear. Recent genotyping s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma
Share to Immunoenzyme Techniques
Share to In Situ Hybridization, Fluorescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Neoplasm Grading

Share to Proto-Oncogene Proteins c-myc

Share to Survival Rate

Share to Tissue Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 23934175
DOI: 10.1007/s11060-013-1221-4
PMCID: PMC3881260

Genes

IDH1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23934175-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.PMID 23934175Read ↗

IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.Semantic proximity Read ↗

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.Semantic proximity Read ↗

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.Semantic proximity Read ↗

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma PatientsSemantic proximity Read ↗

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis.Semantic proximity Read ↗

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.Semantic proximity Read ↗

Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell EnrichmentSemantic proximity Read ↗

IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.Semantic proximity Read ↗

IDH1 mutation of gliomas with long-term survival analysis.Semantic proximity Read ↗

DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomasSemantic proximity Read ↗

Genomic profiles of IDH-mutant gliomas: MYCN amplified IDH-mutant astrocytoma had the worst prognosis and true mixed oligoastrocytoma does not existSemantic proximity Read ↗

Prognostic stratification of gliomatosis cerebri by IDH1 R132H and INA expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.